What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q2 2022?

97 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 113,177,462
Total 13F shares: 26,701,115
Share change: -3,902,099
Total reported value: $77,182,300
Put/Call ratio: 41%
Price per share: $2.89
Number of holders: 97
Value change: -$11,574,558
Number of buys: 40
Number of sells: 79

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	4.5%	5,147,461	$15,442,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	3.3%	3,680,520	$11,041,000	—	31 Mar 2022	13F
Park West Asset Management LLC	13F	Company	2.2%	2,468,587	$7,406,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.3%	1,501,886	$4,506,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.2%	1,375,485	$4,126,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.2%	1,357,176	$4,072,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	1,292,267	$3,876,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.1%	1,244,092	$3,732,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.98%	1,108,028	$3,324,000	—	31 Mar 2022	13F
Sio Capital Management, LLC	13F	Company	0.88%	999,829	$2,999,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.85%	967,349	$2,902,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.57%	648,871	$1,947,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.54%	611,645	$1,835,000	—	31 Mar 2022	13F
Ikarian Capital, LLC	13F	Company	0.47%	532,429	$1,596,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	0.4%	447,400	$1,342,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.32%	365,354	$1,096,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.31%	356,482	$1,070,000	—	31 Mar 2022	13F
MACQUARIE GROUP LTD	13F	Company	0.29%	332,048	$996,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.29%	325,748	$977,000	—	31 Mar 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.1%	109,364	$929,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.23%	263,132	$855,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.25%	282,306	$847,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.25%	277,797	$833,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.23%	260,349	$781,000	—	31 Mar 2022	13F
HRT FINANCIAL LP	13F	Company	0.21%	234,066	$702,000	—	31 Mar 2022	13F
David M. Knott Jr.	13F	Individual	0.2%	228,102	$684,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.2%	222,834	$669,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.17%	196,410	$590,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.16%	176,278	$529,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.15%	166,500	$500,000	—	31 Mar 2022	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.14%	159,717	$479,000	—	31 Mar 2022	13F
Corient Capital Partners, LLC	13F	Company	0.14%	153,959	$462,000	—	31 Mar 2022	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.13%	144,532	$434,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.12%	139,664	$419,000	—	31 Mar 2022	13F
Employees Retirement System of Texas	13F	Company	0.12%	138,826	$416,000	—	31 Mar 2022	13F
Cornerstone Capital, Inc.	13F	Company	0.12%	135,045	$405,000	—	31 Mar 2022	13F
Graham Capital Management, L.P.	13F	Company	0.11%	127,070	$381,000	—	31 Mar 2022	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.11%	123,751	$371,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.11%	119,944	$360,000	—	31 Mar 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.1%	118,706	$356,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.1%	111,159	$333,477	—	31 Mar 2022	13F
FIRST TRUST ADVISORS LP	13F	Company	0.09%	106,928	$321,000	—	31 Mar 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.09%	101,970	$306,000	—	31 Mar 2022	13F
CAXTON ASSOCIATES LP	13F	Company	0.09%	96,671	$290,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	92,483	$277,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.08%	88,757	$266,000	—	31 Mar 2022	13F
PDT Partners, LLC	13F	Company	0.07%	82,239	$247,000	—	31 Mar 2022	13F
ALPS ADVISORS INC	13F	Company	0.07%	80,540	$242,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.07%	79,600	$239,000	—	31 Mar 2022	13F
SG Americas Securities, LLC	13F	Company	0.07%	78,850	$237,000	—	31 Mar 2022	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q2 2022

As of 30 Jun 2022, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,701,115 shares. The largest 10 holders included VANGUARD GROUP INC, Balyasny Asset Management LLC, Park West Asset Management LLC, BlackRock Inc., Laurion Capital Management LP, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, and Sio Capital Management, LLC. This page lists 97 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

131

Q2 2022 holders

Holder diff

-34

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.